Killer Cell Immunoglobulin Like Receptor 2DL3 (KIR2DL3) Antibody (Biotin)

Este producto es parte de KIR2DL3 - Killer cell immunoglobulin-like receptor 2DL3
Product Graph
169€ (20 µg)

Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.

935106861
info@markelab.com
name
Killer Cell Immunoglobulin Like Receptor 2DL3 (KIR2DL3) Antibody (Biotin)
category
Primary Antibodies
provider
Abbexa
reference
abx312861
tested applications
ELISA

Description

KIR2DL3 Antibody (Biotin) is a Rabbit Polyclonal against KIR2DL3 conjugated to Biotin.

Documents del producto

Instrucciones
Data sheet
Descargar

Product specifications

Category
Primary Antibodies
Immunogen Target
Killer Cell Immunoglobulin Like Receptor 2DL3 (KIR2DL3)
Host
Rabbit
Reactivity
Human
Recommended Dilution
Optimal dilutions/concentrations should be determined by the end user.
Clonality
Polyclonal
Conjugation
Biotin
Isotype
IgG
Purity
> 95%
Purification
Purified by Protein G.
Size 1
20 µg
Size 2
50 µg
Size 3
100 µg
Size 4
200 µg
Size 5
1 mg
Form
Liquid
Tested Applications
ELISA
Buffer
0.01 M PBS, pH 7.4, 0.03% Proclin-300 and 50% Glycerol.
Availability
Shipped within 5-10 working days.
Storage
Aliquot and store at -20°C. Avoid exposure to light. Avoid repeated freeze/thaw cycles.
Dry Ice
No
UniProt ID
P43628
Gene ID
3804
NCBI Accession
NP_056952.2, NM_015868.2
OMIM
604938
Alias
CD158 antigen-like family member B2,KIR-023GB,Killer inhibitory receptor cl 2-3,NKAT2a,NKAT2b,GL183,CD158b,KIR2DL
Background
Antibody anti-KIR2DL3
Status
RUO

Descripción

KIR2DL3 is an inhibitory receptor that is part of the killer cell immunoglobulin-like receptor (KIR) family, which is primarily expressed on natural killer (NK) cells and some T-cell subsets. This receptor plays a pivotal role in immune surveillance and modulation by binding to specific HLA class I molecules, particularly HLA-C alleles, on potential target cells. KIR2DL3 recognizes HLA-C1 (characterized by an asparagine at position 80), which is different from HLA-C2 (lysine at position 80) recognized by related receptors like KIR2DL1. By binding to HLA-C1, KIR2DL3 sends inhibitory signals that regulate NK cell cytotoxicity, promoting immune tolerance and minimizing the risk of autoimmunity. The KIR genes, including KIR2DL3, are located on chromosome 19q13.4 in a highly polymorphic region known as the leukocyte receptor complex (LRC). Genetic variability within this complex, particularly in the KIR2DL3 and its HLA-C ligands, contributes to diversity in immune response among individuals. Variants in KIR2DL3 and other KIR genes are associated with differential susceptibility to diseases, including autoimmune disorders, viral infections, and cancers.

Related Products

FNab04581

KIR2DL3 antibody

Receptor on natural killer(NK) cells for HLA-C alleles(HLA-Cw1, HLA-Cw3 and HLA-Cw7). Inhibits the activity of NK cells thus preventing cell lysis.

Ver Producto
Pr22676

Recombinant Human KIR2DL3

Ver Producto
Pr22677

Recombinant Human KIR2DL3

Ver Producto